Sep 26, 2023 09:09AM
Sep 26, 2023 08:59AM
Sep 21, 2023 10:08AM
Sep 21, 2023 10:08AM
Jul 28, 2023 07:41AM
Jul 28, 2023 07:07AM
Jul 28, 2023 07:05AM Biogen to Acquire Reata Pharmaceuticals
Jun 28, 2023 05:21AM
Jun 27, 2023 07:29PM
Jun 16, 2023 06:02AM
Jun 15, 2023 07:15PM
Jun 13, 2023 06:45AM
Jun 13, 2023 06:45AM
Jun 4, 2023 09:00PM Bragar Eagel & Squire, P.C. Is Investigating Phathom, Reata, and Comerica and Encourages Investors to Contact the Firm
May 10, 2023 06:41AM
May 10, 2023 06:40AM
May 2, 2023 05:45PM
Mar 1, 2023 08:40AM
Mar 1, 2023 06:37AM
Mar 1, 2023 05:50AM
Feb 28, 2023 05:36PM FDA confirms approval of Reata Pharma's (RETA) Skyclarys to treat rare degenerative disease
Feb 28, 2023 05:25PM
Feb 28, 2023 05:16PM
Feb 28, 2023 03:06PM
Nov 8, 2022 06:40AM
Oct 20, 2022 04:30PM
Oct 14, 2022 06:18AM
Oct 13, 2022 05:24PM After-Hours Movers: Imara Gains on Merger, Travere Therapeutics Falls on PDUFA Delay
Oct 13, 2022 04:40PM
Oct 13, 2022 04:38PM
Oct 13, 2022 04:37PM
Aug 9, 2022 06:49AM
Aug 9, 2022 06:45AM
Aug 8, 2022 06:45AM
Jul 11, 2022 06:45AM Reata Pharma (RETA) Appoints Steven W. Ryder to its Board
Jul 11, 2022 06:45AM
May 26, 2022 06:46AM
May 26, 2022 06:45AM
May 10, 2022 11:30AM
May 10, 2022 06:40AM
Mar 31, 2022 04:55PM
Mar 31, 2022 04:55PM Reata Pharmaceuticals Completes Rolling Submission of New Drug Application for Omaveloxolone for the Treatment of Patients with Friedreich’s Ataxia
Feb 28, 2022 06:45AM
Feb 25, 2022 05:30PM
Feb 13, 2022 09:00PM
Feb 8, 2022 04:06PM
Feb 8, 2022 12:00PM
Feb 7, 2022 09:00PM
Feb 2, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cloopen Group, Reata, Exicure, and Desktop Metal and Encourages Investors to Contact the Firm
Jan 31, 2022 06:45AM

322,265 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All